Dr. Monther AlAlwan is a scientist at the Stem Cell and Tissue Re-engineering Program (SCTRP), King Faisal Specialist Hospital and Research Centre, as well as an Associate professor at Alfaisal University, Riyadh Saudi Arabia. He holds M.Sc. and Ph.D. in Immunology from Dalhousie University (Halifax, Canada). Dr. AlAlwan conducted a 3-years postdoctoral fellowship studying signaling in immune cells at the University of Manitoba, Canada. During his graduate studies and postdoctoral fellowship, Dr. AlAlwan made substantial contribution in the immunology field, particularly his groundbreaking discovery that highlighted the significance of the dendritic cells in the immunological synapse. After joining the SCTRP in 2007, he shifted gear to study cancer, where he identified novel mechanisms that regulate cancer metastasis and chemoresistance. Currently, he is actively involved in dissecting the molecular pathways that regulate the function of cancer stem cells and how this related to chemoresistance and metastasis. Dr. AlAlwan is an author in 20 peer-reviewed publications, has delivered several invited lectures and is a regular reviewer for various international journals.
Research Interest: Cell Reprogramming and Induced Pluripotent Stem
Cells, Stem Cells and Neural Tissue Engineering, Mammalian Inner Ear
Development and Hair Cell Regeneration.
Research Interest: Leptin Receptors (Lepr) are Expressed by Various
Types of Stem Cells Including Mesenchymal Stem Cells, Hematopoietic Stem Cells,
Embryonic Stem Cells and Induced Pluripotent Stem Cells. Leptin/Lepr Signaling
is also a Central Regulator of Metabolism.
Research Interest: Stem Cell Biology; Breast Cancer Dormancy; Neural
Regulation of Hematopoiesis, the Immunology and Clinical Application of Adult
Human Mesenchymal Stem Cells.
Research Interest: Cancer Stem Cell, Anticancer Agent, Metastasis, Cell
Survival, Cell Migration, Apoptosis, Molecular and Cell Signaling, Transcription
Factors, Xenograft Model, Stem Cell Based Therapy.
Dr. Edgar Grinstein is a Principal Investigator at the Heinrich Heine University in Düsseldorf (Germany). He researches hematopoietic stem cells and progenitor cells, signal transduction, gene transcription regulation. He has more than 11 years of experience as Editor-In-Chief at SAGE Publications Inc. (USA) and Libertas Academica (New Zealand), and also serves as Deputy Editor-In-Chief for Baishideng Publishing Group (USA).
Raised in a family of researchers – both parents are PhD scientists - he received his PhD summa cum laude in Molecular Biology from the Humboldt University and the Max-Delbrück Center for Molecular Medicine in Berlin. He has published a number of papers in high-ranking journals and received a highly regarded Research Award from Dr.-Günther- and Imme-Wille-Foundation. Dr. Grinstein qualified as Professor in Molecular Medicine at the University of Düsseldorf in 2008 and is a Visiting Professor at the University of Latvia (Latvia, European Union) since 2010.
Dr. Grinstein`s research in the field of hematopoietic stem and progenitor cells, funded by research grants from German Research Foundation (DFG) and José Carreras Leukämie-Stiftung (José Carreras Foundation), has focused on markers, signal transduction and transcriptional control. Among other important findings made, his research group provided new insights into the role of the prominent surface marker AC133/CD133 (Leukemia 2015; 29: 2208-2220), that is expressed on stem/progenitor cells in normal hematopoiesis as well as on tumor-initiating cells in certain hematological malignancies. The study analyzed the control of AC133/CD133 expression in hematopoietic stem/progenitor cells, and revealed the impact thereof on molecular network relevant to these cells.
Research Interest: hematopoietic stem cells and progenitor cells, cancer stem cells, stem cell markers, signal transduction, cell cycle control, regulation of apoptosis, gene transcription regulation
Grants: Principal Investigator of stem cell-related projects funded by German Research Foundation (DFG) and by José Carreras Leukämie-Stiftung (José Carreras Foundation)
Grinstein, E., and H.-D. Royer. 1995. Multiple octamer-binding proteins are targets for the cell cycle regulated nuclear inhibitor I-92. DNA Cell Biol. 14: 493-500.
Grinstein, E., I. Weinert, B. Droese, M. Pagano, and H.-D. Royer. 1996. Cell cycle regulation of nuclear factor p92 DNA-binding activity by novel phase-specific inhibitors. J. Biol. Chem. 271: 9215-9222.
Bargou, R.C., C. Wagener, K. Bommert, W. Arnold, P.T. Daniel, M.Y. Mapara, E. Grinstein, H.-D. Royer, and B. Dörken. 1996. Blocking of transcription factor E2F/DP by dominant-negative mutants in a normal breast epithelial cell line efficiently inhibits apoptosis and induces tumor growth in SCID mice. J. Exp. Med. 183: 1205-1213.
Bargou, R.C., F. Emmerich, D. Krappmann, K. Bommert, M.Y. Mapara, W. Arnold, H.-D. Royer, E. Grinstein, A. Greiner, C. Scheidereit, and B. Dörken. 1997. Constitutive nuclear factor kappaB-RelA activation is required for proliferation and survival of Hodkin’s desease tumor cells. J. Clin. Invest. 12: 2961-2969.
Janke, J., K. Schlüter, B. Jandrig, M. Theile, K. Kölble, W. Arnold, E. Grinstein, A. Schwartz, L.E. Schwarz, P.M. Schlag, B.M. Jockusch, and S. Scherneck. 2000. Suppression of tumoriginecity in breast cancer cells by the microfilament protein profilin1. J. Exp. Med. 191: 1675-1685.
Grinstein, E.,* F. Jundt, I. Weinert, P. Wernet, and H.-D. Royer. 2002. Sp1 as G1 cell cycle phase specific transcription factor in epithelial cells. Oncogene. 21: 1485-1492.
Grinstein, E., P. Wernet, P.J. Snijders, F. Rösl, I. Weinert, W. Jia, R. Kraft, Ch. Schewe, M. Schwabe, S. Hauptmann, M. Dietel, Ch. Meijer, and H.-D. Royer. 2002. Nucleolin as activator of human papillomavirus type 18 oncogene transcription in cervical cancer. J. Exp. Med. 196: 1067-1078.
Grinstein, E.,* Y. Shan, L. Karawajew, P.J. Snijders, C.J. Meijer, H.-D. Royer, and P. Wernet. 2006. Cell cycle controlled interaction of nucleolin with the retinoblastoma protein and cancerous cell transformation. J. Biol. Chem. 281: 22223-22235.
Grinstein, E.,* Y. Du, S. Santourlidis, J. Christ, M. Uhrberg, and P. Wernet. 2007. Nucleolin regulates gene expression in CD34 positive hematopoietic cells. J. Biol. Chem. 282: 12439-12449.
Grinstein, E.,* and P. Wernet. 2007. Cellular signaling in normal and cancerous stem cells. Cell. Signal. 19: 2428-2433.
This was the most read article of the Journal Cell. Signal. from July 2007 till March 2008. Source: SCIENCEDIRECT TOP 25 HOTTEST ARTICLES
Wethkamp, N., H. Hanenberg, C. Suschek, W. Wetzel, S. Heikaus, E. Grinstein, U. Ramp, R. Engers, H. Gabbert, and C. Mahotka. 2011. DAXX-beta and DAXX-gamma: two novel splice variants of the transcriptional co-repressor DAXX. J. Biol. Chem. 19576-19588.
Grinstein, E.,* C. Mahotka, and A. Borkhardt. 2011. Rb and nucleolin antagonize in controlling human CD34 gene expression. Cell. Signal. 23: 1358-1365.
Bhatia, S., S. Reister, C. Mahotka, R. Meisel, A. Borkhardt, and E. Grinstein.* 2015. Control of AC133 / CD133 and impact on human hematopoietic progenitor cells through nucleolin. Leukemia. 29: 2208-2220.
Mahotka, C., S. Bhatia, J. Kollet, and E. Grinstein.* 2018. Nucleolin promotes execution of the hematopoietic stem cell gene expression program. Leukemia. 32: 1865–1868.
Reister, S., C. Mahotka, N. van den Höfel, and E. Grinstein.* 2019. Nucleolin promotes Wnt signaling in human hematopoietic stem/progenitor cells. Leukemia. 33: 1052-1054.
Research Interest: Tumor Immunology and Immunotherapy, Cancer Stem
Cell Biology and Immunology, Obstetrics and Gynecology.
Research Interest: Focuses on Aging-Related Diseases and Stem Cell
Research Interest: Clinical Pharmacology, Gastroenterology, Pharmaceutical Development, Drug Development, Colorectal Cancer, Inflammatory Bowel Disease, Ulcerative Colitis, Crohn's Disease
Research Interest: Cardiac Therapy, Cardiovascular Disease,
Autologous, Tissue-Engineering, Multipotent Stem Cells, Cardiovascular
Structures, Regenerative Medicine.
Research Interest: Embryonic Stem Cells, Pluripotency, Induced Pluripotent
Cells, Differentiation, Endoderm, Beta Cell, Diabetes, Obesity, Adipose Tissue,
Brown Fat, Endothelium, Oxidative Stress, Nitric Oxide, Peroxynitrite, Superoxide,
Research Interest: Hematopoietic Stem Cell Transplanting, Cell Therapy
and Everything in the Field of Publication and Education.
Involved in Cell Cycle Regulation, Differentiation, Apoptosis and Senescence
Such as the Retinoblastoma (RB) Family. He has Evaluated the Role of Retinoblastoma
Genes in the Regulation of Cell Proliferation, Differentiation and Apoptosis in
Cancer and Normal Stem Cells. In Detail, his Group has Analyzed the Biology of Neural Stem Cells and Mesenchymal Stem Cells. These Studies Prompted the Attention Also on Chromatin
Remodeling Factors that Interact with RB Family Members and Play a Key Role in the Life of StemCells.
Research Interest: Resident Cardiac Stem Cells, Myocardial
Regeneration in Basic and Clinical/Translational Studies.
Two Major Projects are Currently Underway in the Laboratory.
A Cell Reprogramming Technique Has Been Used to Convert Heterogeneous Malignant Breast Cancer Cells into Induced Pluripotent Stem Cells Using Sox2/Oct4/Nanog Proteins. Dr. Wu’s Laboratory is Clarifying these Induced Pluripotent Stem Cells for their Differentiation Potential and Oncogenic Properties, and Try to Develop a Novel Cell Converting Therapy for Malignant Breast Cancer Treatment.
Metastasis, the Spread of Cancer Cells from the Primary Tumor To Distant Organs, Is The Most Dreadful Development Of Breast Cancer, As Well As Other Neoplastic Diseases. Although Metastasis Contributes To Over 90% Of Human Cancer Mortality, The Molecular Mechanism Of This Process Remains Largely Unknown. Dr. Wu’s Laboratory Is In The Process Of Identifying Molecular Signatures Involved In Breast Cancer Metastasis Using Integrative Genetic, Epigenetic And Proteomic Approach, As Well As Animal Models And Clinical Specimens.
Published On: February 28, 2020 | Pages: 001 - 008Abstract View Full Article View
Published On: December 27, 2019 | Pages: 007 - 011Abstract View Full Article View
Published On: August 03, 2019 | Pages: 000 - 006Abstract View Full Article View
Published On: April 01, 2017 | Pages: 006 - 015Abstract View Full Article View
Published On: December 31, 2016 | Pages: 001 - 005Abstract View Full Article View
Published On: December 29, 2016 | Pages: 025 - 032Abstract View Full Article View
Published On: December 29, 2016 | Pages: 017 - 024Abstract View Full Article View
Published On: December 13, 2016 | Pages: 007 - 016Abstract View Full Article View
Published On: November 29, 2016 | Pages: 001 - 006Abstract View Full Article View
Published On: December 31, 2015 | Pages: 017 - 018Abstract View Full Article View
I wish to continue my services as an editor in this journal for journal growth. The editor and reviewer comments in this journal are good and fair. I suggest that journal should actively participate with different valuable conference and publish papers as conference proceedings. The manuscript submission process is easy and user friendly. I strongly recommend my batch mates and co-scientists to submit their valuable works in this journal for publication. I am satisfied with the manuscript submission and publication time line. I mostly like the blind review process in this journal. I can easily find the required information on the website
It is a pleasure for me to work with the journal and confer my services.The comments from the reviewers/editors are fair and professional. It will be fine, that journal can get more citations. Manuscript submission process is smooth and rapid. I recommend the journal for reputed indexing services. I recommend this journal to others for publication of their valuable research works. I am satisfied with the submission-publication timeline. The required information is easily approachable on the website.
I am happy to be part of the editorial board and I really want to contribute for it!
I wish to associate and contribute to the journal and confer my services. The comments from the reviewers/editors are fair and satisfactory. Manuscript submission process is quick and smooth. I recommend the journal for reputed indexing services. I recommend this journal to others for publication. I am satisfied with the submission-publication timeline. I like most in your publication process is quickness.
I have glad so much because of Journal of Gynecological Research and Obstetrics; service'.
I was always given information about my article.
The Journal (Journal of Gynecological Research and Obstetrics) is exactly suggested to all author.
Journal of Gynecological Research and Obstetrics is very helpful on your manuscript's.
The publishing process thank you very much.
I like to continue as an editor in this journal and give my services. The comments we are getting from editors and reviewers are fair. The journal should send the each and every information of the journal to EB and RB members. Manuscript submission process is easy as well as user friendly. I strongly recommend the journal for getting reputed indexing services. I will intimate my co- researchers to submit their future works in this journal for publication. The manuscript submission and publication time line is more accurate. I mostly like the repaid peer review process in the journal.I can easily find the required information, if needed.
The comments from the reviewers/editors are fair and professional. Selection of reviewers regarding the ability to analyse data according to their Research interest that can be helpful for the growth of the journal. Manuscript submission process is good. I recommend the journal for reputed indexing services. I recommend this journal to others for publication of their valuable works. I like mostly like the Reviewer Evaluation form in the Peer Review process of this journal. The required information is easily approachable on the website.
I wish to associate with the journal as Editor and confer my services. The comments from the reviewers/editors are fair and meaningful. Manuscript submission process is quick and smooth. I recommend the journal to have faster indexing in Pubmed. I recommended this journal to others for publication of their valuable research works. I am satisfied with the submission-publication timeline. The publication process is most effective. The required information is easily available on the website.
I wish to be associated with the journal and confer my services. The comments from the reviewers/editors are fair and meaningful. I suggest to lower the cost for publication, great discounts for first submission. Manuscript submission process is quick and smooth. I recommend the journal for reputed indexing services. I recommend this journal to others for publication. I am satisfied with the submission-publication timeline. Publication process is very fast. The required information is easily approachable on the website.
I do wish to associate with the journal and provide my services if needed. The reviewer and editor comments in this journal are considerable. Manuscript submission process is smoothie. I recommend this journal for getting reputed indexing platforms. I recommend my colleagues and co experts to submit their research works in this journal. The timeline of submission and publication process are satisfactory. I can find the required information in the website easily.
Catholic University of Rome, Italy
Open Journal of Orthopedics and Rheumatology
Metaxas Memorial Anticancer Hospital , Greece
Annals of Bone Marrow Research
Domenico Antonio Restivo
Nuovo Garibaldi Hospital, Italy
Journal of Neurology, Neurological Science and Disorders
Beijing University of Technology , PR China
Journal of Civil Engineering and Environmental Sciences
Lyon Catholic University (UCLy) and Ecole Pratique des Hautes Etudes (EPHE), France
Annals of Cytology and Pathology
China University of Political Science and Law, China
Forensic Science Today
Samy I. McFarlane
State University of New York, Downstate Medical Centre, Brooklyn, New York, USA
International Journal of Clinical Endocrinology and Metabolism
Kyushu University, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan
Global Journal of Cancer Therapy
International Iberian Nanotechnology Laboratory (INL), Portugal
International Journal of Nanomaterials, Nanotechnology and Nanomedicine
Hon. Pierre Guertin
Laval University, Canada
Global Journal of Obesity, Diabetes and Metabolic Syndrome